Detailed results from the CheckMate-816 trial will be shared at an upcoming medical conference More: Opdivo plus chemo improves event-free survival in NSCLC patients Source: News
read moreDesignation granted for the treatment of eosinophilic gastritis with or without eosinophilic gastroenteritis More: AZ announces US fast track designation for IL-5 inhibitor Fasenra Source: News
read moreAround 60% of those eligible have received their booster vaccinations in the UK More: UK gov’t warns of Christmas COVID restrictions, push for booster vaccines Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals